Search Results - "Markićević, M."

Brain mapping across 16 autism mouse models reveals a spectrum of functional connectivity subtypes by Zerbi, V., Pagani, M., Markicevic, M., Matteoli, M., Pozzi, D., Fagiolini, M., Bozzi, Y., Galbusera, A., Scattoni, M. L., Provenzano, G., Banerjee, A., Helmchen, F., Basson, M. A., Ellegood, J., Lerch, J. P., Rudin, M., Gozzi, A., Wenderoth, N.

“…Autism Spectrum Disorder (ASD) is characterized by substantial, yet highly heterogeneous abnormalities in functional brain connectivity. However, the origin…”
Get full text

Early and late tamoxifen resistance in breast cancer by Abu, Rabi, Markicevic, M., Vujasinovic, Tijana, Lukic, Silvana, Stamatovic, Ljiljana, Nikolic-Vukosavljevic, Dragica

“…In our study we investigated the role of the estrogen receptor (ER), progesterone receptor (PR) and clinicohistological parameters in breast cancer patients…”
Get full text

Correction: Brain mapping across 16 autism mouse models reveals a spectrum of functional connectivity subtypes by Zerbi, V., Pagani, M., Markicevic, M., Matteoli, M., Pozzi, D., Fagiolini, M., Bozzi, Y., Galbusera, A., Scattoni, M. L., Provenzano, G., Banerjee, A., Helmchen, F., Basson, M. A., Ellegood, J., Lerch, J. P., Rudin, M., Gozzi, A., Wenderoth, N.

Get full text

Correlation between steroid receptors, angiogenic factors, and classical prognostic parameters in node-negative breast cancer patients by Vujasinovic, Tijana, Markicevic, M., Rabi, Abu, Nikolic-Vukosavljevic, Dragica

“…Breast cancer (BC) progression is an estrogen receptor (ER) signaling- and angiogenesis-dependent process. This study investigated relationships between…”
Get full text

Cathepsin D-related disease-free interval in pT1 primary breast carcinomas: a pilot study by Nikolić-Vukosavljević, D, Markićević, M, Grujić-Adanja, G, Petrović, A, Kanjer, K, Nesković-Konstantinović, Z

“…In order to address the heterogeneity of the pT1 breast cancer stages, we have been examining the natural and the clinical course of disease in relation to…”
Get full text

Clinical utility of portable electrophysiology to measure fatigue in treatment-naïve non-small cell lung cancer by O’Connor, B., Markicevic, M., Newman, L., Poduval, R. K., Tiernan, E., Hanrahan, E., Cuffe, S., Reilly, R. B., Walsh, D.

“…Purpose Cancer-related fatigue (CRF) biology remains poorly understood. Responsible mechanisms may be central or peripheral and originate anywhere from the…”
Get full text

887 Postmenopausal Early Breast Cancer Patients – the Relevance of Quantitative ER Values and Follow-up Periods by Markicevic, M, Vujasinovic, T, Rabi, Z. Abu, Neskovic-Konstantinovic, Z, Stamatovic, L.J, Nikolic-Vukosavljevic, D

Get full text

PP 40 Tumor microenvironment and prognosis in breast carcinoma by Vujasinovic, T, Galon, J, Rabi, Z. Abu, Markicevic, M, Kanjer, K, Neskovic-Konstantinovic, Z, Kieda, C, Nikolic-Vukosavljevic, D

Get full text

Change of influence of prognostic markers on metastasis free interval during and after adjuvant tamoxifen therapy in breast cancer patients by Abu Rabi, Z, Todorovic-Rakovic, N, Markicevic, M, Stamatovic, L, Vujasinovic, T, Nikolic-Vukosavljevic, D

“…To evaluate the influence of molecular biomarkers (estrogen receptor - ER, progesterone receptor - PR, and human epidermal growth factor receptor2 - HER2) and…”
Get more information

Prognosis of estrogen-regulated cathepsin D in pT2,3pN+ breast cancer by Markicevic, M, Nikolic-Vukosavljevic, D, Neskovic-Konstantinovic, Z

Get full text

2024 POSTER Can angiogenic markers bFGF and VEGF predict prognosis in node-negative breast carcinoma? by Nikolic-Vukosavljevic, D, Markicevic, M, Vujasinovic, T, Buta, M, Abu Rabi, Z

Get full text

Natural course of node-negative breast cancer: high risk-related subgroups by Nikolić-Vukosavljević, D, Kanjer, K, Markicević, M, Todorović-Raković, N, Vukotić, D, Nesković-Konstantinović, Z

“…This study attempted to evaluate the first-generation prognostic factors in terms of relapse-free interval in 297 node-negative breast cancer patients treated…”
Get more information

Plasma TGF-β1-related survival of postmenopausal metastatic breast cancer patients by Nikolić-Vukosavljević, D., Todorović-Raković, N., Demajo, M., Ivanović, V., Nešković, B., Markićević, M., Nešković-Konstantinović, Z.

Get full text

Plasma TGF-beta1-related survival of postmenopausal metastatic breast cancer patients by Nikolić-Vukosavljević, D, Todorović-Raković, N, Demajo, M, Ivanović, V, Nesković, B, Markićević, M, Nesković-Konstantinović, Z

“…A pilot study was conducted to assess whether plasma levels of transforming growth factor-beta1 (TGF-beta1) might facilitate biological subgrouping of…”
Get full text

Plasma TGF-[beta]1-related survival of postmenopausal metastatic breast cancer patients by Nikolic-vukosavljevic, D, Todorovic-rakovic, N, Demajo, M, Ivanovic, V, Neskovic, B, Markicevic, M, Neskovic-konstantinovic, Z

“…A pilot study was conducted to assess whether plasma levels of transforming growth factor-β (TGF-β1) might facilitate biological subgrouping of postmenopausal…”
Get full text

Simultaneous determination of steroid hormone receptors and estrogen-regulated proteins pS2 and cathepsin D in breast carcinomas by Nikolic-Vukosavljevic, D., Grujic-Adanja, G., Markicevic, M.

Get full text

P39 Survival of postmenopausal metastatic breast cancerpatients in relation to plasma TGF-betal by Nikolic-Vukosavljevic, D., Todorovic-Rakovic, N., Demajo, M., Ivanovic, V., Neskovic, B., Markicevic, M., Neskovic-Konstantinovic, Z.

Get full text

Association between pS2 and cathepsin-D in breast carcinoma: biological and clinical aspects by Markicevic, M, Nikolic-Vukosavljevic, D, Adanja-Grujic, G

Get full text